Form 4 for NKTR NEKTAR THERAPEUTICS
Accepted 2023-09-20 00:00:00 ET · period of report 2023-09-18 · accession 0001209191-23-050222 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-20 | 2022-09-22 | NKTR | CHESS ROBERT | Dir | S - Sale | $0.67 | -10.2K | 274.8K | -4% | -$6,834 |
| D | 2023-09-20 | 2023-09-19 | NKTR | CHESS ROBERT | Dir | A - Grant | $0.00 | +85.0K | 85.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-22 | S | D | 10,200 | $0.67 | 274,773 | D | — | — | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan. (F2) This transaction was executed in multiple trades at prices ranging from $0.66 to $0.69. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. (F3) Includes 56,794 shares previously reported as shares held in Grantor Retained Annuity Trusts for which the reporting person was the sole trustee. |
| 2 | Derivative | Stock Option | 2023-09-19 | A | A | 85,000 | $0.00 | 85,000 | D | $0.68 · — to 2031-09-18 | 85,000 Common Stock | (F5) This stock option vests in equal monthly installments over the one-year period beginning on September 19, 2023. |